End-of-life care in a COPD patient awaiting lung transplantation: a case report by Daisy JA Janssen et al.
Janssen et al. BMC Palliative Care 2010, 9:6
http://www.biomedcentral.com/1472-684X/9/6
Open AccessC A S E  R E P O R TCase reportEnd-of-life care in a COPD patient awaiting lung 
transplantation: a case report
Daisy JA Janssen*1,2,3, Martijn A Spruit1, Joan D Does1, Jos MGA Schols4 and Emiel FM Wouters1,5
Abstract
COPD is nowadays the main indication for lung transplantation. In appropriately selected patients with end stage 
COPD, lung transplantation may improve quality of life and prognosis of survival. However, patients with end stage 
COPD may die while waiting for lung transplantation. Palliative care is important to address the needs of patients with 
end stage COPD. This case report shows that in a patient with end stage COPD listed for lung transplantation offering 
palliative care and curative-restorative care concurrently may be problematic. If the requirements to remain a 
transplantation candidate need to be met, the possibilities for palliative care may be limited. Discussing the possibilities 
of palliative care and the patient's treatment preferences is necessary to prevent that end-of-life care needs of COPD 
patients dying while listed for lung transplantation are not optimally addressed. The patient's end-of-life care 
preferences may ask for a clear distinction between the period in which palliative and curative-restorative care are 
offered concurrently and the end-of-life care period. This may be necessary to allow a patient to spend the last stage of 
life according to his or her wishes, even when this implicates that lung transplantation is not possible anymore and the 
patient will die because of end stage COPD.
Background
The prevalence and burden of Chronic Obstructive Pul-
monary Disease (COPD) are expected to increase in the
coming decades [1]. By 2020, COPD will rank third as
cause of mortality and fifth as cause of disability world-
wide [2].
The Global Strategy for the Diagnosis, Management,
and Prevention of COPD describes the management of
patients with COPD according to the severity of airflow
limitation [1]. In patients with very severe COPD, surgi-
cal treatments like bullectomy, lung volume reduction
surgery or lung transplantation need to be considered [1].
COPD is nowadays the main indication for lung trans-
plantation [3]. In fact, in appropriately selected patients
with end-stage COPD, lung transplantation may improve
quality of life and prognosis of survival [4,5].
Referral for lung transplantation in COPD patients
should only be considered in patients with progressive
deterioration despite optimal treatment, including smok-
ing cessation, maximal pharmacological treatment, pul-
monary rehabilitation, long-term oxygen therapy and
surgical treatment, if possible [4]. Listing for lung trans-
plantation should occur when the expected prognosis of
survival is significantly reduced, but exceeds the expected
waiting time for lung transplantation [6]. Especially in
COPD, where the survival benefit of lung transplantation
remains debatable, quality of life needs to be taken into
account, next to the survival benefit, in the decision mak-
ing about listing for lung transplantation [4,6]. While
lung transplantation may improve prognosis of survival
and quality of life of some patients with end stage COPD,
other COPD patients will die while waiting for a donor
[7,8].
The importance of addressing the needs of patients
with end stage COPD for palliative care (defined by the
World Health Organization as "an approach that
improves the quality of life of patients and their families
facing the problem associated with life-threatening illness,
through the prevention and relief of suffering by means of
early identification and impeccable assessment and treat-
ment of pain and other problems, physical, psychosocial
and spiritual" [9]) has been shown before [10-12].
Recently has been described the need for a model of care
in which comprehensive palliative care approaches are
embedded within curative-restorative care [12,13]. How-
ever, goals of palliative care and curative-restorative care
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Page 2 of 5may be conflicting. For example, life-prolonging inter-
ventions may interfere with quality of life [14]. To date
remains unknown whether and to what extent offering
palliative care to patients with end stage COPD is influ-
enced by being listed for lung transplantation.
The aim of this case report is to describe palliative and
end-of-life care in a patient with end stage COPD listed
for lung transplantation and to discuss the transition
from curative-restorative care and palliative care to end-
of-life care.
Case Report
A 47-year old woman was admitted to our nursing home
unit for patients with end stage lung disease because of
COPD in June, 2006. She was admitted to the nursing
home following hospitalisation because of an acute
COPD exacerbation. The aim of admission to the special-
ized nursing home unit was providing nursing care and
interdisciplinary care to improve her functional status.
She suffered from COPD since 1991. At time of admis-
sion to the nursing home her forced expiratory volume in
the first second (FEV1) was 15% of predicted values. Her
functional mobility, as assessed by the six minute walking
distance (6MWD) was severely limited (155 meters;
23.6% of predicted values) [15]. In June 2006 she had a
high body mass index (BMI, 27.6 kg/m2) and a low fat free
mass index (14.4 kg/m2). Since 2001 she used long-term
oxygen therapy. She participated in a comprehensive
inpatient pulmonary rehabilitation program four times
(2003, 2004, 2005 and 2006) at Ciro, centre of expertise
for chronic organ failure in Horn, the Netherlands [16].
Since 2005 she was listed for lung transplantation. At that
moment she needed two liters oxygen per minute for 24
hours a day. Her arterial carbon dioxide tension (PaCO2)
was 6.2 kPa. Other surgical procedures, like lung volume
reduction surgery were not possible because of homoge-
neous disease on High Resolution Computed Tomogra-
phy (HRCT) [6].
Although she preferred to stay in her own home, it was
not possible to deliver the care she needed in her home
environment. Her husband suffered from chronic renal
failure and underwent dialysis. He was waiting for kidney
transplantation. In the nursing home she was offered an
interdisciplinary patient-centred management program
aimed at improving functional status to optimise the out-
come of lung transplantation. Exercise training was the
cornerstone of her management program and consisted
of endurance training, resistance training of large muscle
groups of upper and lower extremities, transcutaneous
neuromuscular electrical stimulation of lower-limb mus-
cles, unsupported arm exercises and inspiratory muscle
training (IMT). The occupational therapist supported her
with energy conservation and activity efficiency tech-
niques, aimed at reducing her dependency in tasks of
daily living.
Her disease trajectory was characterized by high sensa-
tion of dyspnea and frequent acute exacerbations. During
her stay in the nursing home she deteriorated progres-
sively. Her dyspnea increased (grade 5 on the Medical
Research Council (MRC) dyspnea scale) [17]. She was
suffering from clinically relevant symptoms of anxiety
measured with the Hospital Anxiety and Depression
Scale (HADS), a validated and reliable measurement
instrument used widely in medically ill patients [18].
Therefore, she was treated by the psychosocial team with
psychological individual counselling and art therapy. The
high sensation of dyspnea and frequent exacerbations
made it difficult for her to adhere to her daily exercise
training program. Indeed, endurance training and even
interval training became very hard for her to accomplish.
Because of her deterioration she was accepted for the
high-priority list for lung transplantation in June, 2007.
At that moment her PaCO2 had increased to 7,6 kPa and
she was prescribed non-invasive positive pressure venti-
lation (NPPV). Unfortunately, because of severe anxiety
for NPPV continuation was not possible. She suffered
form dyspnea at rest and the use of opioids was necessary
to achieve an acceptable level of daily symptom burden
[12,19]. In December 2007 she received a call for lung
transplantation. Unfortunately transplantation was not
possible, because of insufficient quality of the donor
lungs.
In February 2008, she was admitted to the Intensive
Care Unit (ICU) because of progressive respiratory fail-
ure. After discharge she needed increasing dosages opi-
oids to treat her dyspnea. In May 2008 she was again
admitted to the hospital because of a very severe acute
exacerbation of her COPD. At discharge to the nursing
home her functional status had deteriorated severely
(6MWD 55 m; 8.8% of predicted values). Moreover, her
BMI was 31.8 kg/m2, in part because of oedema. She was
admitted to the transplant centre in June 2008 to evaluate
if she was still an appropriate candidate for lung trans-
plantation. Echocardiography showed normal left ven-
tricular systolic function, decreased left ventricular
diastolic function because of impaired relaxation and
normal right ventricular function. She was temporarily
de-listed because of her BMI. The possibility that she
would not survive to transplantation was discussed with
her and her husband. In addition, the possibilities of palli-
ative care and her treatment preferences were discussed.
According to her wishes, goal of the interdisciplinary
patient-centred management program remained improv-
ing functional status. In July 2008 her BMI was 29.8 kg/
m2, her functional mobility improved (6MWD 90 meters;
14.2% of predicted values) and she was again listed with
the intention to transplant. However, a few weeks later
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exacerbation. Her BMI increased and was above 30 kg/
m2. At discharge in September 2008 she was bedbound
and used high dosages of corticosteroids. In addition, her
opioid use had increased during the last months to 40 mg
morphine subcutaneously a day. She had developed dia-
betes mellitus. After evaluation by the transplant centre
she was once again temporarily de-listed and the require-
ments for listing with the intention to transplant were: a
BMI below 30 kg/m2 and lowering her dosage of opioids.
At that moment her life expectancy appeared to be
severely limited. In fact, also her quality of life was
severely impaired, mainly because of high daily symptom
burden. Decreasing the dosage of opioids caused unbear-
able suffering. She could hardly stand the burden of exer-
cise training and the adherence to her strict diet affected
her quality of life even more. At that moment her nursing
home physician discussed again with her the expected
poor prognosis of survival, the things that were impor-
tant in her life and the possibilities for palliative care. She
decided not to undergo mechanical ventilation or cardio-
pulmonary resuscitation in case of progressive respira-
tory failure or cardiac arrest.
In October 2008, the patient and her husband realized
that achieving the requirements for becoming re-listed
was not possible. They decided that the small chance for
surviving to transplantation would not outweigh the bur-
den of continuing curative-restorative treatment. At that
moment she could be offered optimal end-of-life care,
aimed at reducing suffering and improving quality of
dying. Her physical and psychosocial symptoms could be
optimally addressed. In addition, pastoral care supported
her with her existential questions concerning her disease
and dying. The dosage of opioids was titrated to her
needs. Treatments that were burdensome for her were
stopped. In addition, her nursing home physician dis-
cussed with her and her husband the process of dying and
what dying might be like. Although it was very difficult
for her to accept her unpromising situation after so many
years of fighting for lung transplantation, she gradually
accepted her situation. She was finishing the things she
wanted to in her life and started with saying goodbye. In
December 2008, two months after discontinuation of
curative-restorative care, two-and-a-half year after
admission to the nursing home and 3,5 years after listing
for lung transplantation, she died quietly in the nursing
home in the presence of her loved ones.
Discussion
Key findings
This case report describes the difficult process of deci-
sion making in a patient with end stage COPD awaiting
lung transplantation and highlights the difficulty in bal-
ancing the needs for curative-restorative care to prolong
life and the needs for palliative care to improve quality of
life and quality of dying. The burden from curative-
restorative care became too much for this patient towards
the end of life. Therefore, it was necessary to offer end-of-
life care aimed at improving quality of dying instead of
curative-restorative care aimed at achieving again the
requirements for listing for lung transplantation.
Since this patient was listed for lung transplantation she
showed a progressive decline. The transplant criteria
were regularly re-visited and several times she was tem-
porarily de-listed, which had significant consequences for
the patient and her loved ones. Nevertheless, the persis-
tent scarcity of donor lungs asks for a careful selection of
lung transplantation candidates [7]. Although the success
rate of lung transplantation has gradually improved, mor-
bidity and mortality rate immediately post-transplant
remain considerably high [7]. Minimizing the chance of
dying while on the waiting list is justified from the equity
perspective, but wasting of donor lungs need to be
avoided by de-listing of patients without a significant
chance for successful transplantation [7,20].
Despite the fact that palliative care was gradually
offered to this patient during the course of her disease,
offering optimal end-of-life care was not possible if cura-
tive-restorative care had to be continued. For instance, it
would not have been possible to titrate the dosage of opi-
oids to her needs and burdensome treatments would have
been continued. When it was clear that dying was
unavoidable, the patient and her loved ones were pre-
pared for her dying. This enabled them to finish the
things they wanted to do and say goodbye.
Previously, differences in care have been shown at the
end of life between patients with end stage lung disease
listed for lung transplantation and patients not listed for
lung transplantation. Indeed, cystic fibrosis (CF) patients
who were listed for or underwent lung transplantation
were more likely to die in the ICU than CF patients who
were not listed for lung transplantation [21]. Moreover,
CF patients who were listed for or received lung trans-
plantation were more likely to be mechanically ventilated
at or shortly before time of death. They were less likely to
participate in discussions about end-of-life care than CF
patients not listed for transplantation [22].
COPD patients may be confronted with acute life-
threatening exacerbations. Therefore, timely advance
care planning before such a crisis occurs, is necessary to
guide treatment at the end of life [23]. Most patients with
moderate to severe COPD have not discussed their pref-
erences for end-of-life care with their treating physician
[24,25]. However, discussing treatment preferences of
patients with a life-limiting disease is necessary for the
provision of optimal end-of-life care [26]. At time of
referral for lung transplantation, life expectancy is greatly
reduced and therefore the possibilities of palliative care
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the patient and loved ones. However, to date remains
unknown whether and to what extent palliative care is
discussed in COPD patients listed for lung transplanta-
tion.
Predicting prognosis of survival in COPD patients is a
continuous challenge for the treating physician. The dis-
ease trajectory in COPD patients is marked typically by a
gradually decline in health status and daily functioning
and punctuated by acute exacerbations [27]. Every exac-
erbation can be life threatening and is associated with an
increased risk of dying [27]. Because of this disease tra-
jectory, the traditional dichotomous model of curative
and palliative care in which curative care ends and pallia-
tive care starts at a certain moment is not appropriate in
patients with COPD [12]. Therefore, the recent Official
American Thoracic Society Clinical Policy Statement:
Palliative Care for Patients with Respiratory Diseases and
Critical Illnesses describes an individualized integrated
model of palliative care in which palliative care starts
when a patient suffering from a progressive respiratory
disease becomes symptomatic [12]. Palliative care needs
to be offered concurrent with curative-restorative care
and the intensity of palliative care is titrated to the needs
of the patient and the patient's family [12]. However, in
patients listed for lung transplantation offering optimal
palliative care may be limited when curative-restorative
care aimed at staying in optimal physical condition for
lung transplantation needs to be continued. Continuation
of curative-restorative care may implicate that palliative
care needs of COPD patients dying while listed for lung
transplantation, are not optimally addressed. The
patient's preferences for end-of-life care may ask for a
clear distinction between the period in which palliative
and curative-restorative care are offered concurrently and
the end-of-life care period. This may be necessary to
allow a patient to spend the last stage of life according to
his or her wishes, even when this implicates that lung
transplantation is not possible anymore and the patient
will die because of end stage COPD. Choosing the right
moment to discontinue curative care and offer only end-
of-life care, and thereby accept that a patient becomes or
stays de-listed and will die, is very difficult. Therefore, it
is necessary to discuss the patient's preferences for end-
of-life care early in the course of the disease and get to
know and discuss what is important in the patient's life.
These discussions can be framed as 'hope for the best and
prepare for the worst' [10]. In this shared decision making
process it is important to make careful analyses of the
prognosis of survival, the chance for successful lung
transplantation and the burden and benefits from cura-
tive-restorative care compared with the possibilities for
palliative and end-of-life care. The decision to discon-
tinue curative-restorative care and start end-of-life care
aimed at relief of suffering and preparation for the
unavoidable dying can only be made after careful discus-
sions between the patient and his or her loved ones, the
treating chest physician, the transplant centre and the
palliative care physician.
Further research is necessary to elaborate the currently
available knowledge concerning the needs for palliative
care and the access to palliative care for COPD patients
listed for lung transplantation. In addition, further
research is necessary to study the preferences of COPD
patients waiting for lung transplantation for care at the
end of their life.
Conclusions
This case report shows that in a patient with end stage
COPD listed for lung transplantation offering palliative
care and curative-restorative care concurrently may be
problematic. The possibilities for palliative care may be
limited if the requirements to remain a transplantation
candidate need to be met. Discussing the possibilities of
palliative care and the patient's treatment preferences is
necessary to prevent that end-of-life care needs of COPD
patients dying while listed for lung transplantation are
not optimally addressed. The patient's end-of-life care
preferences may ask for a clear distinction between the
period in which palliative and curative-restorative care
are offered concurrently and the period in which is
offered only end-of-life care.
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